Tuberculosis and non-pulmonary malignancies : study of ten cases

##plugins.themes.academic_pro.article.sidebar##

Published Sep 7, 2018
Download
pdf
Vol. 96 No. 6 (2018): Issue Jun 2018

##plugins.themes.academic_pro.article.main##

Hamed Chaabouni
Jihène Féki
Emna Elleuch
Slim Charfi
Afef Khanfir
Nabil Toumi
Tahia Boudawara
Department of Histopathology University Hospital Habib Bourguiba Sfax Tunisia
Mounir Ben Jmea
Jamel Daoud
Mounir Frikha

Abstract

Introduction: Tuberculosis (TBC) is a major public health problem with high mortality especially in developing countries. It is associated with a higher risk of developing pulmonary and non-pulmonary malignancies including solid and hematologic cancers. Association between TBC and nonpulmonary malignancies is rarely described in the literature. The aim of this study is to describe the epidemiological, clinical, therapeutic modalities and the evolutive aspects of patients treated for cancer and TBC.
Patients and methods: This is a retrospective study conducted over a period of 19 years (between 1993 and 2012), including 10 patients followed up for cancer and tuberculosis at the department of oncology and the department of infectious disease, CHU Habib Bourguiba Hospital and CHU HediChaker, Sfax, Tunisia.
Results: The average age of patients was 55 years old. The sex ratio was 1. The different locations of cancer were represented by the breast (4 cases), the nasopharynx (1 case), the colon (1 case), the kidney (1 case) the gum (1 case), the endometrium (1 case) and the blood (1 case).TBC and cancer were synchronous in 5 cases. Concerning the metachronous presentation that interested 5 patients, the average time betweenthe onset of TBC after cancer diagnosis was 3.5 years. Three of these patients were treated by chemotherapy with radiation therapy. TBClocalization was nodal in 6 cases, spinal one case, nasopharyngeal in one case, peritoneal in one case and urogenital in one case. The diagnosisof TBC was made incidentally in two cases during axillary lymph node dissection. The therapeutic management of cancer was based on surgery,chemotherapy and / or radiotherapy. All patients received anti TBC treatment for at least six months. Surgery was indicated in one case(laminectomy). A complete remission of cancer was observed in 9 patients. Concerning TBC, recovery was observed in 8 patients, 1 patient hada spinal recurrence and 1 patient is being treated.
Conclusion: Chronic inflammation during TBC can lead to cancer development. The etiopathogenesis of this association is still imperfectly known.
Association between TBC and non-pulmonary cancer, although rare, should be always kept in mind in order to handle in time these two diseases
in order provide the best chances of recovery for patients.

Keywords:

Tuberculosis, cancer, association, etiology, treatment

##plugins.themes.academic_pro.article.details##

References

  1. Kuo S-C, Hu Y-W, Liu C-J, Lee Y-T, Chen Y-T, Chen T-L, et al. Association between tuberculosis infections and non-pulmonary malignancies: a nationwide population-based study. Br J Cancer 2013;109:229-34.
  2. OMS | Cancer, http://www.who.int/mediacentre/factsheets/fs297/fr/ (accédé le 23 janvier 2015)
  3. Wei WI, Sham JST. Nasopharyngeal carcinoma.Lancet 2005;365:2041-54.
  4. Chen Y-J, Chang Y-T, Wang C-B, Wu C-Y. Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan. Am J Med 2010;123(12):1150.
  5. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012;379:1245-55.
  6. Pandey M, Abraham EK, K C, Rajan B. Tuberculosis and metastatic carcinoma coexistence in axillary lymph node: A case report. World J SurgOncol 2003;1:3.
  7. Bayle, Gaspard-Laurent. Recherches sur la phtisie pulmonaire. A. Delahays, 1855.
  8. Falagas ME, Kouranos VD, Athanassa Z, Kopterides P. Tuberculosis and malignancy. QJM Mon J Assoc Physicians 2010;103:461-87.
  9. Russell DG. Who puts the tubercle in tuberculosis? Nat Rev Microbiol 2007;5:39-47.
  10. Brooks PC, Dawson LF, Rand L, Davis EO. The mycobacterium-specific gene Rv2719c is DNA damage inducible independently of RecA. J Bacteriol 2006;188:6034-8.
  11. Kumar P, Verma A, Saini AK, Chopra P, Chakraborti PK, Singh Y, et al. Nucleoside diphosphate kinase from Mycobacterium tuberculosis cleaves single strand DNA within the human c-myc promoter in an enzyme-catalyzed reaction. NucleicAcidsRes 2005;33:2707-14.
  12. Chan ED, Chan J, Schluger NW. What is the role of nitric oxide in murine and human host defense against tuberculosis?Current knowledge. Am J Respir Cell MolBiol 2001;25:606-12.
  13. Shin D-M, Yang C-S, Lee J-Y, Lee SJ, Choi H-H, Lee H-M, et al. Mycobacterium tuberculosis lipoprotein-induced association of TLR2 with protein kinase C ζ in lipid rafts contributes to reactive oxygen species-dependent inflammatory signalling in macrophages. Cell Microbiol 2008;10:1893-905.
  14. Zhang J, Jiang R, Takayama H, Tanaka Y. Survival of virulent Mycobacterium tuberculosis involves preventing apoptosis induced by Bcl-2 upregulation and release resulting from necrosis in J774 macrophages. MicrobiolImmunol 2005;49:845-52.
  15. Matsuyama W, Kubota R, Hashiguchi T, Momi H, Kawabata M, Nakagawa M, et al. Purified protein derivative of tuberculin upregulates the expression of vascular endothelial growth factor in T lymphocytes in vitro. Immunology 2002;106:96-101.
  16. Wu C-Y, Hu H-Y, Pu C-Y, Huang N, Shen H-C, Li C-P, et al. Pulmonary tuberculosis increases the risk of lung cancer: a population-based cohort study. Cancer 2011;117:618-24.
  17. Yu Y-H, Liao C-C, Hsu W-H, Chen H-J, Liao W-C, Muo C-H, et al. Increased lung cancer risk among patients with pulmonary tuberculosis: a population cohort study. J ThoracOncol Off PublIntAssoc Study Lung Cancer 2011;6:32-7.
  18. Kaplan MH, Armstrong D, Rosen P. Tuberculosis complicating neoplastic disease. A review of 201 cases. Cancer 1974;33:850-8.
  19. WOFFORD JL, WEBB WR, STAUSS H. Tuberculous scarring and primary lung cancer: Clinical and etiologic considerations. Arch Surg 1962;85:928-35.
  20. Shinde SR, Chandawarkar RY, Deshmukh SP. Tuberculosis of the breast masquerading as carcinoma: a study of 100 patients. World J Surg 1995;19:379-81.